Q: I don't have access to any analyst reports. Can you comment on the 3rd q results and if there has been any comments favourable or otherwise.
Thanks.
Thanks.
5i Research Answer:
Revenue of $359M did miss estimates of $378M. EBITDA of $36.1M beat estimates of $25.9M. Results were helped by rate increases in LT Care and home health care. There was also sequential growth in home care volumes, which is not typical in the seasonally weak Q3. Cash flow per share rose to 25c from 14c. Revenue rose 11%. EBITDA rose 74%. These are solid results and the stock is up 8%. Slightly lower earnings are expected next year, however.